Related Experiment Video
Updated: Feb 17, 2026
10:35
An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
19.0K
Immunotherapy in ovarian cancer.
1Department of Gynecologic Oncology, Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, USA.
Summary
The quality of tumor-infiltrating lymphocytes (TILs) is crucial for ovarian cancer outcomes. Developing biomarkers for immunotherapy response is key to durable cures.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Tumor destruction involves a coordinated immune response, including T cell generation, trafficking, and overcoming tumor microenvironment suppression.
- Tumor-infiltrating lymphocytes (TILs) presence correlates with better outcomes in ovarian cancer patients.
- Current immune therapies are approved for many cancers but not yet for ovarian cancer.
Purpose of the Study:
- To review the host immune response in ovarian cancer.
- To discuss progress in immune therapies for ovarian cancer.
- To explore future directions for immune-based strategies to achieve durable cures.
Main Methods:
- Review of existing literature on the cancer immunity cycle and ovarian cancer immunology.
- Analysis of the role of T cell quality in the tumor microenvironment.
- Discussion of current and emerging immunotherapies, including immune checkpoint blockade, cancer vaccines, and adoptive cell therapy.
Main Results:
- The presence of TILs is linked to improved clinical outcomes in ovarian cancer.
- T cell quality, in addition to presence, may be a critical determinant of patient outcomes.
- Ovarian cancer's immune-suppressive microenvironment presents challenges for immunotherapy.
Conclusions:
- Biomarkers are needed to predict immunotherapy response and guide treatment selection in ovarian cancer.
- Rational combinations of immunotherapies, guided by biomarkers, can minimize toxicity and improve efficacy.
- Exploiting immune-based strategies holds promise for achieving long-lasting, durable cures in ovarian cancer.
Keywords:
NY-ESO-1T cellsadoptive cell therapycancer vaccinesimmunomodulationimmunotherapytumor antigensMore Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.2K
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
3.0K
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K